IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases

Rajesh Krishna, Anneliene Jonker, Thomas Morel, Ken Sakushima, Anna Maria Gerdina Pasmooij, Daniel O’Connor

    Research output: Contribution to journalComment/Letter to the editorAcademic

    1 Citation (Scopus)

    Abstract

    New approaches are needed to streamline clinical trials of drugs for patients with rare diseases. Digital biomarkers offer one such approach, but several challenges must be addressed to realize their potential
    Original languageEnglish
    JournalNature Reviews Drug Discovery
    DOIs
    Publication statusE-pub ahead of print/First online - 16 Dec 2024

    Keywords

    • NLA

    Fingerprint

    Dive into the research topics of 'IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases'. Together they form a unique fingerprint.

    Cite this